143 related articles for article (PubMed ID: 38460946)
21. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
22. The value of basement membrane-associated genes in the prognosis and immune regulation of glioma.
Sun Y; Li R; Chen Y; Yang B; Li X; Li Z; He J; Zhou Z; Li J; Guo X; Wang X; Wu Y; Zhang W; Guo G
Medicine (Baltimore); 2023 Jun; 102(23):e33935. PubMed ID: 37335645
[TBL] [Abstract][Full Text] [Related]
23. G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway.
Cheng Y; Heng X; Feng F
Technol Cancer Res Treat; 2022; 21():15330338221105733. PubMed ID: 35770303
[No Abstract] [Full Text] [Related]
24. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway.
Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
[TBL] [Abstract][Full Text] [Related]
25. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
26. An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis.
Wang X; Gao M; Ye J; Jiang Q; Yang Q; Zhang C; Wang S; Zhang J; Wang L; Wu J; Zhan H; Hou X; Han D; Zhao S
Front Genet; 2020; 11():612037. PubMed ID: 33391355
[TBL] [Abstract][Full Text] [Related]
27. High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma.
Deng L; Zeng S; Yi Q; Song L
PeerJ; 2023; 11():e15136. PubMed ID: 37009153
[TBL] [Abstract][Full Text] [Related]
28. miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC.
Zhou DD; Li HL; Liu W; Zhang LP; Zheng Q; Bai J; Hu YQ; Yin CG; Lv SJ; Zhang BG
Biomed Res Int; 2021; 2021():8928509. PubMed ID: 33628829
[TBL] [Abstract][Full Text] [Related]
29. TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma.
Lu Q; Xie Y; Qi X; Yang S
Medicine (Baltimore); 2023 Dec; 102(48):e36410. PubMed ID: 38050264
[TBL] [Abstract][Full Text] [Related]
30. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
Tang W; Xu F; Zhao M; Zhang S
BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
[TBL] [Abstract][Full Text] [Related]
32. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
33. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract][Full Text] [Related]
34. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
35. STEAP3 is a prognostic biomarker that promotes glioma progression by regulating immune microenvironment and PI3K-AKT pathway.
Song Z; Zhao Z; Zhu S; Jin Q; Shi Y; Zhang S; Wang Z; Wang Y; Zhao Z
Cancer Biomark; 2023; 38(4):505-522. PubMed ID: 37980651
[TBL] [Abstract][Full Text] [Related]
36.
Gao X; Liu Y; Hong S; Yang H; Guan B; Ma X
J Integr Neurosci; 2023 Aug; 22(5):135. PubMed ID: 37735118
[TBL] [Abstract][Full Text] [Related]
37. FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.
Sun Z; Sun X; Yuan Y; Li H; Li X; Yao Z
Medicine (Baltimore); 2023 Sep; 102(37):e35084. PubMed ID: 37713871
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas.
Fang Z; Lin L; Tu Z; Zhu X; Li J; Luo P; Huang K; Wu L
Cancer Med; 2023 Jan; 12(1):712-732. PubMed ID: 35702880
[TBL] [Abstract][Full Text] [Related]
39. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
40. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]